American Oncology Network, Inc. (AONC)
OTCMKTS · Delayed Price · Currency is USD
13.50
+0.36 (2.74%)
Jun 27, 2025, 3:48 PM EDT

American Oncology Network Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
41413756---
Upgrade
Market Cap Growth
143.33%143.33%----
Upgrade
Enterprise Value
647423546---
Upgrade
Last Close Price
12.905.065.9010.049.75-
Upgrade
PS Ratio
0.240.080.04---
Upgrade
PB Ratio
3.841.270.80---
Upgrade
EV/Sales Ratio
0.370.240.43---
Upgrade
Debt / Equity Ratio
1.401.401.882.081.070.61
Upgrade
Debt / EBITDA Ratio
15.9215.9232.994.189.111.42
Upgrade
Debt / FCF Ratio
-----1.46
Upgrade
Asset Turnover
4.174.173.654.004.20-
Upgrade
Inventory Turnover
31.1431.1429.4629.6230.52-
Upgrade
Quick Ratio
1.201.201.351.431.371.14
Upgrade
Current Ratio
1.531.531.641.721.751.34
Upgrade
Return on Equity (ROE)
-30.17%-30.17%-54.35%---
Upgrade
Return on Assets (ROA)
-2.38%-2.38%-3.20%1.92%0.25%-
Upgrade
Return on Capital (ROIC)
-4.35%-4.35%-5.68%3.52%0.52%-
Upgrade
Return on Capital Employed (ROCE)
---4.80%0.70%28.20%
Upgrade
Earnings Yield
-2.30%-2.90%-9.84%---
Upgrade
FCF Yield
-6.25%-18.89%-53.95%---
Upgrade
Buyback Yield / Dilution
-460.99%-460.99%----
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.